Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism

ACS Nano. 2012 Aug 28;6(8):6578-91. doi: 10.1021/nn202452c. Epub 2012 Jul 26.

Abstract

A simple method for preparing 5-fluorouracil surface-functionalized selenium nanoparticles (5FU-SeNPs) with enhanced anticancer activity has been demonstrated in the present study. Spherical SeNPs were capped with 5FU through formation of Se-O and Se-N bonds and physical adsorption, leading to the stable structure of the conjugates. 5FU surface decoration significantly enhanced the cellular uptake of SeNPs through endocytosis. A panel of five human cancer cell lines was shown to be susceptible to 5FU-SeNPs, with IC(50) values ranging from 6.2 to 14.4 μM. Despite this potency, 5FU-SeNP possesses great selectivity between cancer and normal cells. Induction of apoptosis in A375 human melanoma cells by 5FU-SeNPs was evidenced by accumulation of sub-G1 cell population, DNA fragmentation, and nuclear condensation. The contribution of the intrinsic apoptotic pathway to the cell apoptosis was confirmed by activation of caspase-9 and depletion of mitochondrial membrane potential. Pretreatment of cells with a general caspase inhibitor z-VAD-fmk significantly prevented 5FU-SeNP-induced apoptosis, indicating that 5FU-SeNP induced caspase-dependent apoptosis in A375 cells. Furthermore, 5FU-SeNP-induced apoptosis was found dependent on ROS generation. Our results suggest that the strategy to use SeNPs as a carrier of 5FU could be a highly efficient way to achieve anticancer synergism. 5FU-SeNPs may be a candidate for further evaluation as a chemopreventive and chemotherapeutic agent for human cancers, especially melanoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Drug Synergism
  • Fluorouracil / administration & dosage*
  • Fluorouracil / chemistry*
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Nanocapsules / administration & dosage*
  • Nanocapsules / chemistry*
  • Selenium / administration & dosage*
  • Selenium / chemistry*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Nanocapsules
  • Selenium
  • Fluorouracil